Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Food on Blood Levels of ASTX727
- Status
- COMPLETED
- Phase
- PHASE1
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
- Status
- RECRUITING
- Phase
- NA
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
- Status
- TERMINATED
- Phase
- PHASE1
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA